Literature DB >> 32530997

Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection.

David Yardeni1, Vitali Dizengof2, Anat Nevo-Shor3, Naim Abufreha4, Harel Dahari5, Ohad Etzion6.   

Abstract

.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32530997      PMCID: PMC7351150          DOI: 10.15403/jgld-2153

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  4 in total

1.  A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis.

Authors:  Marco Masetti; Donatella Magalotti; Elena Martino; Pietro Andreone; Alessandra Scuteri; Marco Zoli
Journal:  J Gastrointestin Liver Dis       Date:  2016-12       Impact factor: 2.008

2.  Sustained virological response after 4-week ritonavir-boosted paritaprevir, ombitasvir and dasabuvir plus ribavirin treatment in a kidney transplant recipient.

Authors:  Claudio Calvanese; Andrea Lisotti; Saverio Fiorenza; Marcora Mandreoli; Giancarlo Caletti; Pietro Fusaroli
Journal:  J Gastrointestin Liver Dis       Date:  2017-09       Impact factor: 2.008

Review 3.  Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.

Authors:  Benoit Chauvin; Sylvain Drouot; Aurélie Barrail-Tran; Anne-Marie Taburet
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

4.  Modeling HCV cure after an ultra-short duration of therapy with direct acting agents.

Authors:  Ashish Goyal; Yoav Lurie; Eric G Meissner; Marian Major; Natasha Sansone; Susan L Uprichard; Scott J Cotler; Harel Dahari
Journal:  Antiviral Res       Date:  2017-06-30       Impact factor: 5.970

  4 in total
  1 in total

1.  Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study.

Authors:  Ohad Etzion; Harel Dahari; David Yardeni; Assaf Issachar; Anat Nevo-Shor; Michal Cohen-Naftaly; Yaffa Ashur; Susan L Uprichard; Orly Sneh Arbib; Daniela Munteanu; Marius Braun; Scott J Cotler; Naim Abufreha; Ayelet Keren-Naus; Yonat Shemer-Avni; Orna Mor; Jayanah Murad; Victor Novack; Amir Shlomai
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.